Literature DB >> 28477121

Peptide Immunoaffinity Enrichment with Targeted Mass Spectrometry: Application to Quantification of ATM Kinase Phospho-Signaling.

Jeffrey R Whiteaker1, Lei Zhao1, Regine M Schoenherr1, Jacob J Kennedy1, Richard G Ivey1, Amanda G Paulovich2.   

Abstract

Peptide immunoaffinity enrichment coupled with targeted mass spectrometry is a quantitative approach for the robust and reproducible quantification of peptide analytes. The approach is capable of multiplexed quantification of peptides, including posttranslational modifications such as phosphorylation. Anti-peptide antibodies are used to enrich analytes and heavy stable isotope-labeled standards. The enriched peptides are directly measured by multiple reaction monitoring (MRM), a well-characterized quantitative mass spectrometry-based method. Quantification is performed by measuring the analyte (light) peptide response relative to the heavy standard, which is spiked at a known concentration. Here, we describe the methodology for multiplexed measurement of phosphorylated peptides on the ATM kinase and their nonmodified peptide analogs in cellular lysates. The method provides quantitative measurements of phospho-signaling and can be extended to a number of other phosphopeptides and sample types.

Entities:  

Keywords:  DNA damage response; LC/MS; Multiplex; Quantitation; Targeted proteomics

Mesh:

Substances:

Year:  2017        PMID: 28477121      PMCID: PMC5555734          DOI: 10.1007/978-1-4939-6955-5_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

Review 1.  Antibodies as means for selective mass spectrometry.

Authors:  Tove Boström; Jenny Ottosson Takanen; Sophia Hober
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-10-31       Impact factor: 3.205

2.  Sequential multiplexed analyte quantification using peptide immunoaffinity enrichment coupled to mass spectrometry.

Authors:  Jeffrey R Whiteaker; Lei Zhao; Chenwei Lin; Ping Yan; Pei Wang; Amanda G Paulovich
Journal:  Mol Cell Proteomics       Date:  2011-12-27       Impact factor: 5.911

3.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Authors:  Terri A Addona; Susan E Abbatiello; Birgit Schilling; Steven J Skates; D R Mani; David M Bunk; Clifford H Spiegelman; Lisa J Zimmerman; Amy-Joan L Ham; Hasmik Keshishian; Steven C Hall; Simon Allen; Ronald K Blackman; Christoph H Borchers; Charles Buck; Helene L Cardasis; Michael P Cusack; Nathan G Dodder; Bradford W Gibson; Jason M Held; Tara Hiltke; Angela Jackson; Eric B Johansen; Christopher R Kinsinger; Jing Li; Mehdi Mesri; Thomas A Neubert; Richard K Niles; Trenton C Pulsipher; David Ransohoff; Henry Rodriguez; Paul A Rudnick; Derek Smith; David L Tabb; Tony J Tegeler; Asokan M Variyath; Lorenzo J Vega-Montoto; Asa Wahlander; Sofia Waldemarson; Mu Wang; Jeffrey R Whiteaker; Lei Zhao; N Leigh Anderson; Susan J Fisher; Daniel C Liebler; Amanda G Paulovich; Fred E Regnier; Paul Tempst; Steven A Carr
Journal:  Nat Biotechnol       Date:  2009-06-28       Impact factor: 54.908

4.  Skyline: an open source document editor for creating and analyzing targeted proteomics experiments.

Authors:  Brendan MacLean; Daniela M Tomazela; Nicholas Shulman; Matthew Chambers; Gregory L Finney; Barbara Frewen; Randall Kern; David L Tabb; Daniel C Liebler; Michael J MacCoss
Journal:  Bioinformatics       Date:  2010-02-09       Impact factor: 6.937

5.  Proteomics meets the scientific method.

Authors:  Paola Picotti; Bernd Bodenmiller; Ruedi Aebersold
Journal:  Nat Methods       Date:  2013-01       Impact factor: 28.547

6.  Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays.

Authors:  Andrew N Hoofnagle; Jeffrey R Whiteaker; Steven A Carr; Eric Kuhn; Tao Liu; Sam A Massoni; Stefani N Thomas; R Reid Townsend; Lisa J Zimmerman; Emily Boja; Jing Chen; Daniel L Crimmins; Sherri R Davies; Yuqian Gao; Tara R Hiltke; Karen A Ketchum; Christopher R Kinsinger; Mehdi Mesri; Matthew R Meyer; Wei-Jun Qian; Regine M Schoenherr; Mitchell G Scott; Tujin Shi; Gordon R Whiteley; John A Wrobel; Chaochao Wu; Brad L Ackermann; Ruedi Aebersold; David R Barnidge; David M Bunk; Nigel Clarke; Jordan B Fishman; Russ P Grant; Ulrike Kusebauch; Mark M Kushnir; Mark S Lowenthal; Robert L Moritz; Hendrik Neubert; Scott D Patterson; Alan L Rockwood; John Rogers; Ravinder J Singh; Jennifer E Van Eyk; Steven H Wong; Shucha Zhang; Daniel W Chan; Xian Chen; Matthew J Ellis; Daniel C Liebler; Karin D Rodland; Henry Rodriguez; Richard D Smith; Zhen Zhang; Hui Zhang; Amanda G Paulovich
Journal:  Clin Chem       Date:  2016-01       Impact factor: 8.327

7.  Antibody-Coupled Magnetic Beads Can Be Reused in Immuno-MRM Assays To Reduce Cost and Extend Antibody Supply.

Authors:  Lei Zhao; Jeffrey R Whiteaker; Uliana J Voytovich; Richard G Ivey; Amanda G Paulovich
Journal:  J Proteome Res       Date:  2015-08-31       Impact factor: 4.466

8.  Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry.

Authors:  Michael A Gillette; Steven A Carr
Journal:  Nat Methods       Date:  2013-01       Impact factor: 28.547

9.  Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.

Authors:  Steven A Carr; Susan E Abbatiello; Bradley L Ackermann; Christoph Borchers; Bruno Domon; Eric W Deutsch; Russell P Grant; Andrew N Hoofnagle; Ruth Hüttenhain; John M Koomen; Daniel C Liebler; Tao Liu; Brendan MacLean; D R Mani; Elizabeth Mansfield; Hendrik Neubert; Amanda G Paulovich; Lukas Reiter; Olga Vitek; Ruedi Aebersold; Leigh Anderson; Robert Bethem; Josip Blonder; Emily Boja; Julianne Botelho; Michael Boyne; Ralph A Bradshaw; Alma L Burlingame; Daniel Chan; Hasmik Keshishian; Eric Kuhn; Christopher Kinsinger; Jerry S H Lee; Sang-Won Lee; Robert Moritz; Juan Oses-Prieto; Nader Rifai; James Ritchie; Henry Rodriguez; Pothur R Srinivas; R Reid Townsend; Jennifer Van Eyk; Gordon Whiteley; Arun Wiita; Susan Weintraub
Journal:  Mol Cell Proteomics       Date:  2014-01-17       Impact factor: 5.911

10.  Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics.

Authors:  D R Mani; Susan E Abbatiello; Steven A Carr
Journal:  BMC Bioinformatics       Date:  2012-11-05       Impact factor: 3.169

View more
  7 in total

1.  Quantitative targeted proteomic analysis of potential markers of tyrosine kinase inhibitor (TKI) sensitivity in EGFR mutated lung adenocarcinoma.

Authors:  Shivangi Awasthi; Tapan Maity; Benjamin L Oyler; Yue Qi; Xu Zhang; David R Goodlett; Udayan Guha
Journal:  J Proteomics       Date:  2018-04-13       Impact factor: 4.044

Review 2.  Phosphoproteomics: a valuable tool for uncovering molecular signaling in cancer cells.

Authors:  Jacqueline S Gerritsen; Forest M White
Journal:  Expert Rev Proteomics       Date:  2021-09-16       Impact factor: 4.250

Review 3.  Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation.

Authors:  Ernesto S Nakayasu; Marina Gritsenko; Paul D Piehowski; Yuqian Gao; Daniel J Orton; Athena A Schepmoes; Thomas L Fillmore; Brigitte I Frohnert; Marian Rewers; Jeffrey P Krischer; Charles Ansong; Astrid M Suchy-Dicey; Carmella Evans-Molina; Wei-Jun Qian; Bobbie-Jo M Webb-Robertson; Thomas O Metz
Journal:  Nat Protoc       Date:  2021-07-09       Impact factor: 17.021

4.  Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types.

Authors:  Qi Liu; Luis Palomero; Jade Moore; Ines Guix; Roderic Espín; Alvaro Aytés; Jian-Hua Mao; Amanda G Paulovich; Jeffrey R Whiteaker; Richard G Ivey; George Iliakis; Daxian Luo; Anthony J Chalmers; John Murnane; Miquel Angel Pujana; Mary Helen Barcellos-Hoff
Journal:  Sci Transl Med       Date:  2021-02-10       Impact factor: 17.956

5.  pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry.

Authors:  Gemma N Jones; Claire Rooney; Nicola Griffin; Martine Roudier; Lucy A Young; Antonio Garcia-Trinidad; Gareth D Hughes; Jeffrey R Whiteaker; Zena Wilson; Rajesh Odedra; Lei Zhao; Richard G Ivey; William J Howat; Elizabeth A Harrington; J Carl Barrett; Antonio Ramos-Montoya; Alan Lau; Amanda G Paulovich; Elaine B Cadogan; Andrew J Pierce
Journal:  Br J Cancer       Date:  2018-11-02       Impact factor: 7.640

6.  Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition.

Authors:  Jeffrey R Whiteaker; Tao Wang; Lei Zhao; Regine M Schoenherr; Jacob J Kennedy; Ulianna Voytovich; Richard G Ivey; Dongqing Huang; Chenwei Lin; Simona Colantonio; Tessa W Caceres; Rhonda R Roberts; Joseph G Knotts; Jan A Kaczmarczyk; Josip Blonder; Joshua J Reading; Christopher W Richardson; Stephen M Hewitt; Sandra S Garcia-Buntley; William Bocik; Tara Hiltke; Henry Rodriguez; Elizabeth A Harrington; J Carl Barrett; Benedetta Lombardi; Paola Marco-Casanova; Andrew J Pierce; Amanda G Paulovich
Journal:  Cancers (Basel)       Date:  2021-07-30       Impact factor: 6.575

Review 7.  Non-Antibody-Based Binders for the Enrichment of Proteins for Analysis by Mass Spectrometry.

Authors:  Oladapo Olaleye; Natalia Govorukhina; Nico C van de Merbel; Rainer Bischoff
Journal:  Biomolecules       Date:  2021-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.